Note that some links will break as pages are moved, websites are abandoned, etc.
If this happens, please try searching for the page in the Wayback Machine at www.archive.org.
Read the original article
"While drugs in the U.S. must undergo extensive testing and monitoring to ensure their safety and efficacy, supplements come under much weaker regulation. In a perspective article in The New England Journal of Medicine, Dr. Pieter A. Cohen criticizes the current deficiencies in the regulation of the supplement industry. He argues that a new guidance proposal by the FDA makes important steps toward enhancing supplement safety — but it still doesn’t go far enough." Health Facts and Fears (26th January 2012)